Shots: The US FDA has approved the BLA filing for Jemperli for adult patients with dMMR recurrent or advanced solid tumors endometrial cancer, as determined by an FDA-approved test, that […]readmore
Tags : Endometrial Cancer
Shots: The US FDA has approved Ventana MMR RxDx panel to identify endometrial cancer patients who are eligible for treatment with GSK’s Jemperli (monothx.) that has received the US FDA’s […]readmore
Shots: The P-III KEYNOTE-775/Study 309 trial involves assessing Keytruda (200mg, IV, q3w) + Lenvima (20mg, PO, qd) vs CT Doxorubicin (60 mg/m2, IV, q3wks.) or Paclitaxel (80 mg/m2, IV, 28-day […]readmore